Biomarkers in Chronic Obstructive Pulmonary Disease: Emerging Roles of Eosinophils and Procalcitonin
Antibiotics can improve the prognosis in patients with exacerbation of chronic obstructive pulmonary disease. However, the overuse of antibiotics can carry serious adverse effects for patients (gastrointestinal infections) and for society (bacterial resistance). Likewise, systemic corticosteroids ma...
Main Authors: | Pradeesh Sivapalan, Jens-Ulrik Jensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-08-01
|
Series: | Journal of Innate Immunity |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/517161 |
Similar Items
-
Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
by: Pradeesh Sivapalan, et al.
Published: (2021-02-01) -
Relationship between serum procalcitonin level and chronic obstructive pulmonary disease
by: Hamid Borsi, et al.
Published: (2019-01-01) -
Biomarkers in Pneumonia—Beyond Procalcitonin
by: Meropi Karakioulaki, et al.
Published: (2019-04-01) -
Serum Procalcitonin in Chronic Obstructive Pulmonary Disease
by: Farzaneh Akbari, et al.
Published: (2021-03-01) -
Procalcitonin: Promising biomarker to detect sepsis in burns – A prospective study
by: H R. Naveen Kumar, et al.
Published: (2018-01-01)